Can microRNA profiling in maternal blood identify women at risk for preterm birth?

American Journal of Obstetrics and Gynecology

Volumn 212, Issue 6, 2015, Pages 782.e1-782.e5

  Elovitz, Michal A ^a   Anton, Lauren ^a   Bastek, Jamie ^a   Brown, Amy G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biomarker; microRNA; preterm birth

Indexed keywords

MICRORNA; MICRORNA 200A; MICRORNA 4695; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PROCEDURES; HUMAN; MATERNAL BLOOD; MATERNAL SERUM; MICROARRAY ANALYSIS; MICRORNA PROFILING; PREMATURE LABOR; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; TERM BIRTH; BLOOD; PREDICTIVE VALUE; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDY; RISK ASSESSMENT; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MICRORNAS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84931566692     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.01.023     Document Type: Article

References (24)

1. P.J. Meis, M. Klebanoff, and M. Thom Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
2. E.B. Fonseca, E. Celik, M. Parra, M. Singh, and K.H. Nicolaides Progesterone and the risk of preterm birth among women with a short cervix N Engl J Med 357 2007 462 469
3. E.B. Fonseca, R.E. Bittar, M.H. Carvalho, and M. Zugaib Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study Am J Obstet Gynecol 188 2003 419 424
4. J. Owen, G. Hankins, and J.D. Iams Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length Am J Obstet Gynecol 201 2009 375.e1 375.e8
5. J.A. Bastek, and M.A. Elovitz The role and challenges of biomarkers in spontaneous preterm birth and preeclampsia Fertil Steril 99 2013 1117 1123
6. S.Q. Wei, W. Fraser, and Z.C. Luo Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review Obstet Gynecol 116 2010 393 401
7. A. Conde-Agudelo, A.T. Papageorghiou, S.H. Kennedy, and J. Villar Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis BJOG 118 2011 1042 1054
8. S.M. Eacker, T.M. Dawson, and V.L. Dawson The interplay of microRNA and neuronal activity in health and disease Front Cell Neurosci 7 2013 136
9. T.A. Farazi, J.I. Hoell, P. Morozov, and T. Tuschl MicroRNAs in human cancer Adv Exp Med Biol 774 2013 1 20
10. S. Hagiwara, P. Kantharidis, and M.E. Cooper MicroRNA as biomarkers and regulator of cardiovascular development and disease Curr Pharm Des 2014 2347 2370
11. M. Hulsmans, and P. Holvoet MicroRNAs as early biomarkers in obesity and related metabolic and cardiovascular diseases Curr Pharm Des 19 2013 5704 5717
12. M. Angulo, E. Lecuona, and J.I. Sznajder Role of microRNAs in lung disease Arch Bronconeumol 48 2012 325 330
13. M. Abdellatif Differential expression of microRNAs in different disease states Circ Res 110 2012 638 650
14. T. Bratkovic, G. Glavan, B. Strukelj, M. Zivin, and B. Rogelj Exploiting microRNAs for cell engineering and therapy Biotechnol Adv 30 2012 753 765
15. J. Fiedler, S.K. Gupta, and T. Thum MicroRNA-based therapeutic approaches in the cardiovascular system Cardiovasc Ther 30 2012 e9
16. R. Gambari, E. Fabbri, and M. Borgatti Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development Biochem Pharmacol 82 2011 1416 1429
17. J.A. Bastek, A.L. Weber, M.A. McShea, M.E. Ryan, and M.A. Elovitz Prenatal inflammation is associated with adverse neonatal outcomes Am J Obstet Gynecol 210 2014 450.e1 450.e10
18. J.A. Bastek, M.D. Sammel, and S.K. Srinivas Clinical prediction rules for preterm birth in patients presenting with preterm labor Obstet Gynecol 119 2012 1119 1128
19. E. Aydoʇdu, A. Katchy, and E. Tsouko MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer Carcinogenesis 33 2012 1502 1511
20. Q. Cao, K. Lu, S. Dai, Y. Hu, and W. Fan Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer Int J Clin Exp Pathol 7 2014 2392 2401
21. C.W. Kan, M.A. Hahn, and G.B. Gard Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer BMC Cancer 12 2012 627
22. H.H. Cheng, P.S. Mitchell, and E.m. Kroh Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia PloS One 8 2013 e69239
23. K.C. Williams, N.E. Renthal, J.C. Condon, R.D. Gerard, and C.R. Mendelson MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor Proc Natl Acad Sciences U S A 109 2012 7529 7534
24. M.A. Elovitz, A.G. Brown, and L. Anton Distinct cervical microRNA profiles are present in women destined to have a preterm birth Am J Obstet Gynecol 210 2014 221.e1 221.e11